Streetbeat News

Price Targets

TMO

Thermo Fisher Scientific Inc (TMO) has been downgraded to Sector Weight from Overweight by KeyBanc Capital Markets analyst Paul Knight, following a Q3 revenue miss and lowered outlook for FY23. The company's management expressed concerns about cash conservatism from biotech customers, weakness in China, possible destocking, and overall industry decline. Other analysts from Morgan Stanley, Raymond James, and Citigroup also lowered their price targets for TMO.

Portfolio Pulse from Lekha Gupta

October 26, 2023 | 6:09 pm

FBIN

Truist Securities analyst Keith Hughes has maintained a 'Buy' rating on Fortune Brands (NYSE:FBIN) but lowered the price target from $75 to $65.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:08 pm

EW

Truist Securities analyst Richard Newitter has maintained a 'Buy' rating on Edwards Lifesciences (NYSE:EW) but lowered the price target from $83 to $76.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:04 pm

CME

CME Group Inc reported better-than-expected Q3 earnings with an adjusted EPS of $2.25, surpassing the estimate of $2.22. However, the quarterly revenue of $1.338 billion slightly missed the consensus of $1.342 billion. Following the earnings announcement, Barclays, Rosenblatt, and Morgan Stanley adjusted their price targets on CME Group. The company's shares rose 0.9% to trade at $216.03 on Thursday.

Portfolio Pulse from Lisa Levin

October 26, 2023 | 6:03 pm

AVY

Truist Securities analyst Michael Roxland has maintained a 'Buy' rating on Avery Dennison (NYSE:AVY), but lowered the price target from $215 to $209.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:03 pm

APH

Truist Securities analyst William Stein maintains a 'Buy' rating on Amphenol (NYSE:APH) but has lowered the price target from $101 to $97.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:01 pm

LYV

Guggenheim analyst Curry Baker maintains a Buy rating on Live Nation Entertainment (NYSE:LYV) and raises the price target from $124 to $125.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 5:57 pm

TMO

RBC Capital analyst Conor McNamara has maintained an 'Outperform' rating on Thermo Fisher Scientific (NYSE:TMO) but lowered the price target from $657 to $579.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 5:52 pm

WM

RBC Capital analyst Walter Spracklin maintains a 'Sector Perform' rating on Waste Management (NYSE:WM) and raises the price target from $160 to $163.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 5:50 pm

BA

RBC Capital analyst Ken Herbert has maintained a 'Sector Perform' rating on Boeing (NYSE:BA) but lowered the price target from $210 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 5:48 pm